Evidence map›Paper›PMID 30012698›Full record

ArticleJournal of clinical pathology2018

Three-tiered score for Ki-67 and p16

Marjolein van Zummeren, Annemiek Leeman, Wieke W Kremer, Maaike C G Bleeker, David Jenkins, Miekel van de Sandt, Daniëlle A M Heideman, Renske Steenbergen, Peter J F Snijders, Wim G V Quint and 2 more

Abstract readComparative Study
In one paragraph

Article in Journal of clinical pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Assessing telomerase and Ki-67 protein expression in pre-invasive lesions and invasive cervical neoplasia with correlation to clinico-pathological parameters.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. p16International journal of cancer · 2025
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. GLUT1, LDHA, and MCT4 Expression Is Deregulated in Cervical Cancer and Precursor Lesions.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  18. Article
  19. Cervical Carcinoma: Oncobiology and Biomarkers.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marjolein van ZummerenDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Annemiek Leeman *DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Wieke W Kremer *Department of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Maaike C G BleekerDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
David JenkinsDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Miekel van de SandtDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Daniëlle A M HeidemanDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Renske SteenbergenDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Peter J F SnijdersDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Wim G V QuintDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Johannes BerkhofDepartment of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo investigate the accuracy and reproducibility of a scoring system for cervical intraepithelial neoplasia (CIN1-3) based on immunohistochemical (IHC) biomarkers Ki-67 and p16

methods115 cervical tissue specimens were reviewed by three expert gynaecopathologists and graded according to three strategies: (1) CIN grade based on H&E staining only; (2) immunoscore based on the cumulative score of Ki-67 and p16

resultsWe found that immunoscoring with positivity definition 6 yielded the highest proportion of test positives for

conclusionsThe higher accuracy and reproducibility of the immunoscore opens the possibility of a more standardised and reproducible definition of CIN grade than conventional pathology practice, allowing a more accurate comparison of CIN-based management strategies and evaluation of new biomarkers to improve the understanding of progression of precancer from human papillomavirus infection to cancer.

Indexed as

ImmunohistochemistryBiopsyCross-Sectional StudiesCyclin-Dependent Kinase Inhibitor p16FemaleHumansKi-67 AntigenNeoplasm GradingObserver VariationPapillomaviridaePapillomavirus InfectionsPredictive Value of TestsReference StandardsReproducibility of ResultsRetrospective StudiesUterine Cervical DysplasiaCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Ki-67 Antigencervical cancerdiagnosisHPVimmunohistochemistryKi 67

Identifiers

PMID30012698
PMCPMC6225805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.